Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amiodarone for Ebola Virus Disease
NCT02307591Phase 3Withdrawn
- Sponsor
- EMERGENCY
- Start
- Dec 2014
- Primary completion
- Jul 2015
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of amiodarone in Ebola virus disease (EVD), sponsored by EMERGENCY. Planned start Dec 2014; status: withdrawn.
02
Drugs
amiodarone
03
Conditions
Ebola virus disease (EVD)
Beyond the preview
Go deeper on NCT02307591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02307591.